+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

From
From
From
From
From
From
From
Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Postoperative Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Postoperative Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Peripheral Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Ocular Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Ocular Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 65 Pages
  • Global
From
Hyperalgesia - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperalgesia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
TRPV1 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

TRPV1 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more